Screenings
for breast cancer in older women has risen but that doesn’t necessarily
mean that the result is earlier breast cancer detection. There has
been a large increase in the use of digital mammography technology,
which is more expensive than standard film technology, but it has not
shown that it’s more effective in detecting breast cancer in women aged
65 and older, according to a study done at the Yale School of Medicine.
Overall, Medicare spending for breast cancer screenings and related
procedures rose from $666 million in 2001-2002 to $962 million in
2008-2009, according to the study.
An
assistant professor engaged in the study expressed concern about the
cost of sustainability because the increase has been so noticeable. The
professor also said that guidelines for breast cancer screenings for
older women need to be established to minimize unnecessary biopsies/or
over-diagnosis as well as cost control.
New
technologies, which are theoretically superior but financially
unsustainable can’t be sustained by the health care system; and the
patients deserve to know which treatments are effective and which
aren’t.
The
United States Preventive Services Task Force does not recommend breast
cancer screening for women age 75 years and older, but the study found
that Medicare still spent an increasing amount per woman 75 years and
older in the study.
Typically,
breast cancers treated with a lumpectomy require radiation therapy
following surgery to ensure the lowest risk of recurrence. Standard
radiation treatment requires patients to return after healing from
surgery to begin daily radiation treatment to the entire breast five
days per week, for a total of three to six weeks.
It’s
believed that the new, more expensive treatment option will help women
who live in rural areas because they are often less likely to travel a
great distances for their breast cancer treatments. Distance can create
an obstacle for women to repeatedly return for radiation treatment.
Unfortunately, these women often choose to have a mastectomy in order to
avoid the need for radiation and more travel.
The
new technology is still not widely available in the United States, but
has been used in Europe since the 1990s. And it started being used more
extensively in the United States about a decade ago and has been
studied in clinical trials.
According
to the American Cancer Society, approximately 40,000 women die annually
from breast cancer and 232,670 new cases will be diagnosed in women
each year.
This study was supported by the National Cancer Institute and the Cancer Center Support Grant at the Yale Cancer Center.
No comments:
Post a Comment